Deepak K. Gaur
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Recombinant full-length Bacillus Anthracis protective antigen and its 63 kDa form elicits protective response in formulation with addavax.
Journal: Frontiers in immunology
Published: October 20, 2022
Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique.
Journal: NPJ vaccines
Published: August 08, 2022
Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA).
Journal: Frontiers in immunology
Published: July 28, 2022
Use of recombinant calflagin protein as a potential candidate for diagnosis of Trypanosoma evansi infection.
Journal: Veterinary parasitology
Published: May 23, 2022
Plasmodium falciparum and Helminth Coinfections Increase IgE and Parasite-Specific IgG Responses.
Journal: Microbiology spectrum
Published: December 08, 2021
Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.
Journal: Infection and immunity
Published: October 25, 2021
Genetic disruption of Plasmodium falciparum Merozoite surface antigen 180 (PfMSA180) suggests an essential role during parasite egress from erythrocytes.
Journal: Scientific reports
Published: March 11, 2021
Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.
Journal: The Journal of infectious diseases
Published: August 03, 2020
Erratum: Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique.
Journal: NPJ vaccines
Published: July 25, 2020
Potent in vivo antimalarial activity of water-soluble artemisinin nano-preparations.
Journal: RSC advances
Published: June 26, 2020
RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.
Journal: Vaccine
Published: May 18, 2020
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.
Journal: Scientific reports
Published: March 19, 2020
Last Updated: 09/26/2026